Literature DB >> 31363857

Modern Medical Management of Spinal Cord Injury.

Michael Karsy1, Gregory Hawryluk2.   

Abstract

PURPOSE OF REVIEW: Spinal cord injury (SCI) shows an incidence of 10.4-83 cases/million/year globally and remains a significant source of morbidity and cost to society. Despite greater understanding of the pathophysiology of SCI, neuroprotective and regenerative approaches to treatment have had limited clinical utility to date. Here, we review the key components of supportive care that are thus the mainstay of therapy and that have improved outcomes for victims of acute SCI in recent decades. RECENT STUDIES: Current management strategies for acute SCI involve early surgical decompression and fixation, the use of vasopressor medications for mean arterial blood pressure (MAP) augmentation to improve spinal cord perfusion, and corticosteroids. We highlight recent literature supporting the role of norepinephrine in acute SCI management and also an emerging neurocritical care strategy that seeks to optimize spinal cord perfusion pressure with the assistance of invasive monitoring. This review will highlight key pathophysiologic principles and targets for current acute clinical treatments in SCI, which include early surgical decompression, MAP augmentation, and corticosteroids. We discuss anticipated future research in these areas and focus on potential risks inherent to these treatments.

Entities:  

Keywords:  Blood pressure; Corticosteroids; Decompression; Methylprednisolone; Spinal cord injury; Vasopressor

Year:  2019        PMID: 31363857     DOI: 10.1007/s11910-019-0984-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  46 in total

Review 1.  Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies.

Authors:  B H Juurlink; P G Paterson
Journal:  J Spinal Cord Med       Date:  1998-10       Impact factor: 1.985

Review 2.  Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord.

Authors:  P G Popovich
Journal:  Prog Brain Res       Date:  2000       Impact factor: 2.453

Review 3.  Guidelines for the management of acute cervical spine and spinal cord injuries.

Authors:  Mark N Hadley; Beverly C Walters; Paul A Grabb; Nelson M Oyesiku; Gregory J Przybylski; Daniel K Resnick; Timothy C Ryken; Debbie H Mielke
Journal:  Clin Neurosurg       Date:  2002

4.  Expression of aquaporin water channels in mouse spinal cord.

Authors:  K Oshio; D K Binder; B Yang; S Schecter; A S Verkman; G T Manley
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

5.  Early acute management in adults with spinal cord injury: a clinical practice guideline for health-care professionals.

Authors: 
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

Review 6.  Review of current evidence for apoptosis after spinal cord injury.

Authors:  M S Beattie; A A Farooqui; J C Bresnahan
Journal:  J Neurotrauma       Date:  2000-10       Impact factor: 5.269

Review 7.  Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey?

Authors:  M Wyndaele; J-J Wyndaele
Journal:  Spinal Cord       Date:  2006-01-03       Impact factor: 2.772

8.  Intrathecal pressure monitoring and cerebrospinal fluid drainage in acute spinal cord injury: a prospective randomized trial.

Authors:  Brian K Kwon; Armin Curt; Lise M Belanger; Arlene Bernardo; Donna Chan; John A Markez; Stephen Gorelik; Gerard P Slobogean; Hamed Umedaly; Mitch Giffin; Michael A Nikolakis; John Street; Michael C Boyd; Scott Paquette; Charles G Fisher; Marcel F Dvorak
Journal:  J Neurosurg Spine       Date:  2009-03

9.  Greatly improved neurological outcome after spinal cord compression injury in AQP4-deficient mice.

Authors:  Samira Saadoun; B Anthony Bell; A S Verkman; Marios C Papadopoulos
Journal:  Brain       Date:  2008-02-11       Impact factor: 13.501

10.  Early versus delayed decompression for traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS).

Authors:  Michael G Fehlings; Alexander Vaccaro; Jefferson R Wilson; Anoushka Singh; David W Cadotte; James S Harrop; Bizhan Aarabi; Christopher Shaffrey; Marcel Dvorak; Charles Fisher; Paul Arnold; Eric M Massicotte; Stephen Lewis; Raja Rampersaud
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

View more
  43 in total

Review 1.  Significance of spinal cord perfusion pressure following spinal cord injury: A systematic scoping review.

Authors:  Cameron M Gee; Brian K Kwon
Journal:  J Clin Orthop Trauma       Date:  2022-09-11

Review 2.  Recent Advances in the Role of Nuclear Factor Erythroid-2-Related Factor 2 in Spinal Cord Injury: Regulatory Mechanisms and Therapeutic Options.

Authors:  Tianqi Jiang; Yongxiong He
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

Review 3.  Stem Cell Therapy for Spinal Cord Injury: A Review of Recent Clinical Trials.

Authors:  Emmanouil I Damianakis; Ioannis S Benetos; Dimitrios Stergios Evangelopoulos; Aikaterini Kotroni; John Vlamis; Spyridon G Pneumaticos
Journal:  Cureus       Date:  2022-04-28

4.  Synchronized and integrated prehospital treatment for acute cervical spinal cord injury.

Authors:  Yanlin Yin; Xinming Yang; Ye Tian; Ying Zhang; Peinan Zhang; Yongli Jia; Yao Yao; Xiuyu Du; Tianmin Li; Xiaodong Li
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

5.  SU16f inhibits fibrotic scar formation and facilitates axon regeneration and locomotor function recovery after spinal cord injury by blocking the PDGFRβ pathway.

Authors:  Ziyu Li; Shuisheng Yu; Yanchang Liu; Xuyang Hu; Yiteng Li; Zhaoming Xiao; Yihao Chen; Dasheng Tian; Xinzhong Xu; Li Cheng; Meige Zheng; Juehua Jing
Journal:  J Neuroinflammation       Date:  2022-04-16       Impact factor: 9.587

6.  Promoting functions of microRNA-29a/199B in neurological recovery in rats with spinal cord injury through inhibition of the RGMA/STAT3 axis.

Authors:  Weijie Yang; Ping Sun
Journal:  J Orthop Surg Res       Date:  2020-09-18       Impact factor: 2.359

7.  Unlocking the Recovery Potential: JMJD3 Inhibition-Mediated SAPK/JNK Signaling Inactivation Supports Endogenous Oligodendrocyte-Lineage Commitment Post Mammalian Spinal Cord Injury.

Authors:  Zhang Bo-Yin; Zhu Qingsan; Ma Yihang; Yang Fan; Zhu Yuhang; Chang Pengyu
Journal:  Neurochem Res       Date:  2021-01-11       Impact factor: 3.996

8.  Inhibition of lncRNA H19/miR-370-3p pathway mitigates neuronal apoptosis in an in vitro model of spinal cord injury (SCI).

Authors:  Xin Li; Yan Qian; Kaihua Tang; Yang Li; Rui Tao; Chunyan Gong; Li Huang; Kaiwen Zou; Lindong Liu
Journal:  Transl Neurosci       Date:  2021-03-01       Impact factor: 1.757

9.  Role of melatonin in the dynamics of acute spinal cord injury in rats.

Authors:  Jiaqi Bi; Jianxiong Shen; Chong Chen; Zheng Li; Haining Tan; Peiyu Sun; Youxi Lin
Journal:  J Cell Mol Med       Date:  2021-01-26       Impact factor: 5.310

10.  Effect of Durotomy versus Myelotomy on Tissue Sparing and Functional Outcome after Spinal Cord Injury.

Authors:  Zin Z Khaing; Lindsay N Cates; Dane M Dewees; Jeffrey E Hyde; Ashley Gaing; Zeinab Birjandian; Christoph P Hofstetter
Journal:  J Neurotrauma       Date:  2020-12-18       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.